Bcl-2 and CD99 immunohistochemistry were used to distinguish a hemangiopericytoma from a solitary fibrous tumor because a solitary fibrous tumor is positive for Bcl-2 [7] and CD99 [8]. This evidence concerns the gene BCL2 and hemangiopericytoma.